Αποτελέσματα Αναζήτησης
Radiotherapy (RT) plays a major role in the curative treatment of locally advanced non-small cell lung cancer (NSCLC). Therefore, the ACROP committee was asked by the ESTRO to provide recommendations on target volume delineation for standard clinical scenarios in definitive (chemo)radiotherapy (RT) ….
- Characterizing Pulmonary Function Test Changes for Patients With Lung ...
Traditional radiation therapy techniques for locally...
- Characterizing Pulmonary Function Test Changes for Patients With Lung ...
The current review gives a practical overview on procedures for pre-treatment imaging and target volume delineation in locally advanced non-small cell lung cancer (NSCLC) in synopsis of the procedures established by the PET-Plan trial with the actual EORTC and ACROP guidelines.
14 Απρ 2021 · Small-cell lung cancer (SCLC) is the most aggressive form of lung cancer. Although SCLC is characterised by rapid responses to chemotherapy (ChT) and sensitivity to radiotherapy (RT), due to early treatment resistance, the 5-year overall survival (OS) is <10%. 1 The incidence of SCLC has decreased in recent decades, and with a prevalence of 1-5 ...
29 Ιουλ 2022 · Radiation therapy (RT) is an established treatment for all stages of non-small cell lung cancer (NSCLC), from definitive RT for early-stage disease to palliative RT for advanced and metastatic disease. Identifying the appropriate RT target for each patient starts at...
Treatment Recommendations, Early or Localized Disease. Stage IB (> 4 cm tumor size) or II disease. Surgery is recommended for patients with stage I B (> 4 cm tumor size) or II non–small cell...
1 Μαΐ 2020 · Konert T, Vogel WV, Everitt S, et al. Multiple training interventions significantly improve reproducibility of PET/CT-based lung cancer radiotherapy target volume delineation using an IAEA study protocol.
30 Νοε 2022 · Traditional radiation therapy techniques for locally advanced lung cancer focus on standard lung dose metrics such as mean lung dose, or volume of the lung receiving ≥20 Gy, to reduce the risk of patients developing clinical symptoms. 1 Lung dose metrics assume spatially homogeneous lung function without considering potential functional ...
